US, UK, Canada Agree On Good Machine Learning Practices
Executive Summary
The principals recommended by the three countries could be the foundation for how their regulatory bodies intend to regulate future AI/ML products.
You may also be interested in...
FDA Publishes 5 PCCP Principles For ML Devices In Collaboration With Canada And UK
Five guiding principles for PCCPs for ML devices exemplify international harmonization efforts from regulators.
FDA’s CDER Is Fostering Use Of Artificial Intelligence In Drug Development
Center for Drug Evaluation and Research plans to issue a request for information this year to engage stakeholders on issues related to AI and machine learning. It received 175 AI/ML submissions in 2022, up from 14 in 2020.
Digital Health Roundup: Digital Therapeutics Push Ahead On Standards, Coverage; FDA’s Software Guidance
In this roundup feature focusing on developments in digital health, we highlight the key news and announcements from October.